Annual EPS
-$1.50
+$2.87+65.68%
December 31, 2023
Summary
- As of February 12, 2025, TVTX annual earnings per share is -$1.50, with the most recent change of +$2.87 (+65.68%) on December 31, 2023.
- During the last 3 years, TVTX annual EPS has risen by +$2.06 (+57.87%).
- TVTX annual EPS is now -147.32% below its all-time high of $3.17, reached on December 31, 2015.
Performance
TVTX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.70
+$0.21+23.08%
September 30, 2024
Summary
- As of February 12, 2025, TVTX quarterly earnings per share is -$0.70, with the most recent change of +$0.21 (+23.08%) on September 30, 2024.
- Over the past year, TVTX quarterly EPS has increased by +$0.48 (+40.68%).
- TVTX quarterly EPS is now -135.53% below its all-time high of $1.97, reached on September 30, 2023.
Performance
TVTX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$4.55
-$2.67-142.02%
September 30, 2024
Summary
- As of February 12, 2025, TVTX TTM earnings per share is -$4.55, with the most recent change of -$2.67 (-142.02%) on September 30, 2024.
- Over the past year, TVTX TTM EPS has dropped by -$2.94 (-182.61%).
- TVTX TTM EPS is now -304.04% below its all-time high of $2.23, reached on December 31, 2015.
Performance
TVTX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
TVTX EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.7% | +40.7% | -182.6% |
| 3 y3 years | +57.9% | +32.0% | -4.1% |
| 5 y5 years | +40.9% | +32.0% | -4.1% |
TVTX EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.7% | -135.5% | +60.2% | -211.6% | at low |
| 5 y | 5-year | at high | +65.7% | -135.5% | +70.5% | -211.6% | +0.2% |
| alltime | all time | -147.3% | +81.9% | -135.5% | +78.5% | -304.0% | +24.7% |
Travere Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.70(-23.1%) | -$4.55(+142.0%) |
| Jun 2024 | - | -$0.91(-48.3%) | -$1.88(-10.5%) |
| Mar 2024 | - | -$1.76(+49.2%) | -$2.10(+30.4%) |
| Dec 2023 | -$1.50(-65.7%) | -$1.18(-159.9%) | -$1.61(+10.3%) |
| Sep 2023 | - | $1.97(-274.3%) | -$1.46(-67.7%) |
| Jun 2023 | - | -$1.13(-11.0%) | -$4.52(+1.8%) |
| Mar 2023 | - | -$1.27(+23.3%) | -$4.44(+1.6%) |
| Dec 2022 | -$4.37(+45.2%) | -$1.03(-5.5%) | -$4.37(+4.5%) |
| Sep 2022 | - | -$1.09(+3.8%) | -$4.18(+13.6%) |
| Jun 2022 | - | -$1.05(-12.5%) | -$3.68(+12.5%) |
| Mar 2022 | - | -$1.20(+42.9%) | -$3.27(+7.9%) |
| Dec 2021 | -$3.01(-15.4%) | -$0.84(+42.4%) | -$3.03(-33.6%) |
| Sep 2021 | - | -$0.59(-7.8%) | -$4.56(+3.4%) |
| Jun 2021 | - | -$0.64(-33.3%) | -$4.41(+1.4%) |
| Mar 2021 | - | -$0.96(-59.5%) | -$4.35(+29.1%) |
| Dec 2020 | -$3.56(+2.9%) | -$2.37(+438.6%) | -$3.37(+98.2%) |
| Sep 2020 | - | -$0.44(-24.1%) | -$1.70(-19.4%) |
| Jun 2020 | - | -$0.58(-3000.0%) | -$2.11(-13.9%) |
| Mar 2020 | - | $0.02(-102.9%) | -$2.45(-29.2%) |
| Dec 2019 | -$3.46(+36.2%) | -$0.70(-17.6%) | -$3.46(+17.7%) |
| Sep 2019 | - | -$0.85(-7.6%) | -$2.94(-14.3%) |
| Jun 2019 | - | -$0.92(-7.1%) | -$3.43(+11.7%) |
| Mar 2019 | - | -$0.99(+450.0%) | -$3.07(+20.9%) |
| Dec 2018 | -$2.54(+64.9%) | -$0.18(-86.6%) | -$2.54(-12.7%) |
| Sep 2018 | - | -$1.34(+139.3%) | -$2.91(+43.3%) |
| Jun 2018 | - | -$0.56(+21.7%) | -$2.03(+12.2%) |
| Mar 2018 | - | -$0.46(-16.4%) | -$1.81(+8.4%) |
| Dec 2017 | -$1.54 | -$0.55(+19.6%) | -$1.67(+24.6%) |
| Sep 2017 | - | -$0.46(+35.3%) | -$1.34(-28.7%) |
| Jun 2017 | - | -$0.34(+6.3%) | -$1.88(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$0.32(+45.5%) | -$1.91(+14.4%) |
| Dec 2016 | -$1.29(-140.7%) | -$0.22(-78.0%) | -$1.67(+5.0%) |
| Sep 2016 | - | -$1.00(+170.3%) | -$1.59(-233.6%) |
| Jun 2016 | - | -$0.37(+362.5%) | $1.19(+43.4%) |
| Mar 2016 | - | -$0.08(-42.9%) | $0.83(-62.8%) |
| Dec 2015 | $3.17(-171.6%) | -$0.14(-107.9%) | $2.23(+87.4%) |
| Sep 2015 | - | $1.78(-343.8%) | $1.19(-183.2%) |
| Jun 2015 | - | -$0.73(-155.3%) | -$1.43(-2.7%) |
| Mar 2015 | - | $1.32(-211.9%) | -$1.47(-75.7%) |
| Dec 2014 | -$4.43(+81.6%) | -$1.18(+40.5%) | -$6.04(+6.3%) |
| Sep 2014 | - | -$0.84(+9.1%) | -$5.68(+2.3%) |
| Jun 2014 | - | -$0.77(-76.3%) | -$5.55(+6.9%) |
| Mar 2014 | - | -$3.25(+296.3%) | -$5.19(+116.3%) |
| Dec 2013 | -$2.44(-70.6%) | -$0.82(+15.5%) | -$2.40(+49.1%) |
| Sep 2013 | - | -$0.71(+73.2%) | -$1.61(+73.1%) |
| Jun 2013 | - | -$0.41(-10.9%) | -$0.93(+69.1%) |
| Mar 2013 | - | -$0.46(+1433.3%) | -$0.55(+323.1%) |
| Dec 2012 | -$8.29(+5821.4%) | - | - |
| Nov 2012 | - | -$0.03(0.0%) | -$0.13(0.0%) |
| Aug 2012 | - | -$0.03(0.0%) | -$0.13(0.0%) |
| May 2012 | - | -$0.03(-25.0%) | -$0.13(0.0%) |
| Feb 2012 | - | -$0.04(+33.3%) | -$0.13(+1.3%) |
| Feb 2012 | -$0.14(-36.4%) | - | - |
| Nov 2011 | - | -$0.03(0.0%) | -$0.13(+23.1%) |
| Aug 2011 | - | -$0.03(0.0%) | -$0.10(+40.4%) |
| May 2011 | - | -$0.03(-21.7%) | -$0.07(+67.9%) |
| Feb 2011 | -$0.22 | -$0.04(+549.2%) | -$0.04(+649.2%) |
| Nov 2010 | - | -$0.01(<-9900.0%) | -$0.01(<-9900.0%) |
| Aug 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00 | $0.00 |
FAQ
- What is Travere Therapeutics annual earnings per share?
- What is the all time high annual EPS for Travere Therapeutics?
- What is Travere Therapeutics annual EPS year-on-year change?
- What is Travere Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Travere Therapeutics?
- What is Travere Therapeutics quarterly EPS year-on-year change?
- What is Travere Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Travere Therapeutics?
- What is Travere Therapeutics TTM EPS year-on-year change?
What is Travere Therapeutics annual earnings per share?
The current annual EPS of TVTX is -$1.50
What is the all time high annual EPS for Travere Therapeutics?
Travere Therapeutics all-time high annual earnings per share is $3.17
What is Travere Therapeutics annual EPS year-on-year change?
Over the past year, TVTX annual earnings per share has changed by +$2.87 (+65.68%)
What is Travere Therapeutics quarterly earnings per share?
The current quarterly EPS of TVTX is -$0.70
What is the all time high quarterly EPS for Travere Therapeutics?
Travere Therapeutics all-time high quarterly earnings per share is $1.97
What is Travere Therapeutics quarterly EPS year-on-year change?
Over the past year, TVTX quarterly earnings per share has changed by +$0.48 (+40.68%)
What is Travere Therapeutics TTM earnings per share?
The current TTM EPS of TVTX is -$4.55
What is the all time high TTM EPS for Travere Therapeutics?
Travere Therapeutics all-time high TTM earnings per share is $2.23
What is Travere Therapeutics TTM EPS year-on-year change?
Over the past year, TVTX TTM earnings per share has changed by -$2.94 (-182.61%)